» Articles » PMID: 6726390

Experiences with the Anti-siphon Device (ASD) in Shunt Therapy of Pediatric Hydrocephalus

Overview
Journal J Neurosurg
Specialty Neurosurgery
Date 1984 Jul 1
PMID 6726390
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

A follow-up study was performed on 41 hydrocephalic children with primary (10 patients) or secondary (31 patients) placement of an anti-siphon device (ASD) connected to their shunt. The clinical course before and after ASD implantation was compared in these two groups, including studies of the head circumference, the radiological ventricular size, cerebrospinal fluid pressure studies on the supine and upright patient, and the history of shunt-induced complaints and complications leading to hospitalization. The authors discuss the pathophysiological concept of the "chronic overdrainage " or slit-ventricle syndrome based on ventricular collapse due to chronic suction-induced overdrainage by the vertical shunt system in the upright patient. The use of an ASD in connection with the regular shunt system of children with hydrocephalus is proposed. This ASD-shunt combination successfully reduced the number of complaints and shunt dysfunctions over a period of more than 6 years.

Citing Articles

Optimization of number and range of shunt valve performance levels in infant hydrocephalus: a machine learning analysis.

Waterstraat M, Dehghan A, Gholampour S Front Bioeng Biotechnol. 2024; 12:1352490.

PMID: 38562668 PMC: 10982383. DOI: 10.3389/fbioe.2024.1352490.


A single center experience of adjusting valve pressure ventriculoperitoneal shunts for the treatment of hydrocephalus in infants under 6 months old.

Cattani A, Schwarzer F, Schwarzer M, Spyrantis A, Marquardt G, Schubert-Bast S PLoS One. 2023; 18(3):e0282571.

PMID: 36928724 PMC: 10019726. DOI: 10.1371/journal.pone.0282571.


The Role of Antisiphon Devices in the Prevention of Central Ventricular Catheter Obliteration for Hydrocephalus: A 15-Years Institution's Experience Retrospective Analysis.

Panagopoulos D, Strantzalis G, Gavra M, Boviatsis E, Korfias S Children (Basel). 2022; 9(4).

PMID: 35455537 PMC: 9028279. DOI: 10.3390/children9040493.


Retrospective single-center historical comparative study between proGAV and proGAV2.0 for surgical revision and implant duration.

Brunner E, Schaumann A, Pennacchietti V, Schulz M, Thomale U Childs Nerv Syst. 2022; 38(6):1155-1163.

PMID: 35353205 PMC: 9156487. DOI: 10.1007/s00381-022-05490-y.


Efficacy and safety of the Miethke programmable differential pressure valve (proGAV®2.0): a single-centre retrospective analysis.

Hall B, Gillespie C, Hennigan D, Bagga V, Mallucci C, Pettorini B Childs Nerv Syst. 2021; 37(8):2605-2612.

PMID: 34021371 PMC: 8342385. DOI: 10.1007/s00381-021-05162-3.